DURHAM Hemophilia. Cystic fibrosis. Duchenne muscular dystrophy. Huntingtons disease. These are just a few of the thousands of disorders caused by mutations in the bodys DNA. Treating the root causes of these debilitating diseases has become possible only recently, thanks to the development of genome editing tools such as CRISPR, which can change DNA sequences in cells and tissues to correct fundamental errors at the source but significant hurdles must be overcome before genome-editing treatments are ready for use in humans.
Enter the National Institutes of Health Common FundsSomatic Cell Genome Editing (SCGE)program, established in 2018 to help researchers develop and assess accurate, safe and effective genome editing therapies for use in the cells and tissues of the body (aka somatic cells) that are affected by each of these diseases.
Todaywith three ongoing grants totaling more than $6 million in research fundingDuke University is tied with Yale University, UC Berkeley and UC Davis for the most projects supported by the NIH SCGE Program.
In the 2019 SCGE awards cycle, Charles Gersbach, the Rooney Family Associate Professor of Biomedical Engineering, and collaborators across Duke and North Carolina State University received two grants: the first will allow them to study how CRISPR genome editing affects engineered human muscle tissues, while the second project will develop new CRISPR tools to turn genes on and off rather than permanently alter the targeted DNA sequence. This work builds on a 2018 SCGE grant, led by Aravind Asokan, professor and director of gene therapy in the Department of Surgery, which focuses on using adeno-associated viruses to deliver gene editing tools to neuromuscular tissue.
Duke engineers improve CRISPR genome editing with biomedical tails
There is an amazing team of engineers, scientists and clinicians at Duke and the broader Research Triangle coalescing around the challenges of studying and manipulating the human genome to treat diseasefrom delivery to modeling to building new tools, said Gersbach, who with his colleagues recently launched the Duke Center for Advanced Genomic Technologies (CAGT), a collaboration of the Pratt School of Engineering, Trinity College of Arts and Sciences, and School of Medicine. Were very excited to be at the center of those efforts and greatly appreciate the support of the NIH SCGE Program to realize this vision.
For their first grant, Gersbach will collaborate with fellow Duke biomedical engineering faculty Nenad Bursac and George Truskey to monitor how genome editing affects engineered human muscle tissue. Through their new project, the team will use human pluripotent stem cells to make human muscle tissues in the lab, specifically skeletal and cardiac muscle, which are often affected by genetic diseases. These systems will then serve as a more accurate model for monitoring the health of human tissues, on-target and off-target genome modifications, tissue regeneration, and possible immune responses during CRISPR-mediated genome editing.
Duke researchers: Single CRISPR treatment provides long-term benefits in mice
Currently, most genetic testing occurs using animal models, but those dont always accurately replicate the human response to therapy, says Truskey, the Goodson Professor of Biomedical Engineering.
Bursac adds, We have a long history of engineering human cardiac and skeletal muscle tissues with the right cell types and physiology to model the response to gene editing systems like CRISPR. With these platforms, we hope to help predict how muscle will respond in a human trial.
Gersbach will work with Tim Reddy, a Duke associate professor of biostatistics and bioinformatics, and Rodolphe Barrangou, the Todd R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University, on the second grant. According to Gersbach, this has the potential to extend the impact of genome editing technologies to a greater diversity of diseases, as many common diseases, such as neurodegenerative and autoimmune conditions, result from too much or too little of certain genes rather than a single genetic mutation. This work builds on previous collaborations between Gersbach, Barrangou and Reddy developing bothnew CRISPR systems for gene regulationandto regulate the epigenome rather than permanently delete DNA sequences.
Aravind Asokan leads Dukes initial SCGE grant, which explores the the evolution of next generation of adeno-associated viruses (AAVs), which have emerged as a safe and effective system to deliver gene therapies to targeted cells, especially those involved in neuromuscular diseases like spinal muscular atrophy, Duchenne muscular dystrophy and other myopathies. However, delivery of genome editing tools to the stem cells of neuromuscular tissue is particularly challenging. This collaboration between Asokan and Gersbach builds on their previous work in usingAAV and CRISPR to treat animal models of DMD.
We aim to correct mutations not just in the mature muscle cells, but also in the muscle stem cells that regenerate skeletal muscle tissue, explainsAsokan. This approach is critical to ensuring long-term stability of genome editing in muscle and ultimately we hope to establish a paradigm where our cross-cutting viral evolution approach can enable efficient editing in multiple organ systems.
Click through to learn more about theDuke Center for Advanced Genomic Technologies.
(C) Duke University
- European Wellness Collaborates with Heidelberg University Germany to Conduct Efficacy Studies of Peptides and Cell Therapy Research - WILX-TV - October 28th, 2021
- What are the different kinds of stem cells? | American for ... - October 28th, 2021
- The translatome of neuronal cell bodies, dendrites, and axons - pnas.org - October 28th, 2021
- Virtual Care Market to Witness Exponential Growth by 2031 - BioSpace - October 28th, 2021
- The Rise of Longevity Therapeutics - Pharmaceutical Executive - May 28th, 2021
- Tooth Regeneration Market Size | COVID-19 Impact Analysis | Forecast to 2027 investigated in the latest research - WhaTech - May 28th, 2021
- Global Induced Pluripotent Stem Cell (iPS Cell) Market Report 2021: In Total, At Least 68 Distinct Market Competitors Now Offer Various Types of iPSC... - April 18th, 2021
- Emergent drift of Dental Regenerative Products Market By the World in Upcoming Year 2021-2027 with Leading Key Players: Provia Laboratories, LLC,... - April 18th, 2021
- Worldwide Cell Therapy Industry to 2027 - Increasing Prevalence of Chronic Diseases is Driving the Market - PRNewswire - April 4th, 2021
- Outlook on the Cell Therapy Global Market to 2027 - by Therapy Type, Product, Technology, Application, End-user and Geography - GlobeNewswire - April 4th, 2021
- Exclusive Report on Global Gene Therapy Market Analysis Report 2021 and Forecast to 2029 with different segments, Key players KSU | The Sentinel... - April 4th, 2021
- Stem Cells- Definition, Properties, Types, Uses, Challenges - February 4th, 2021
- Experts Predict the Hottest Life Science Tech in 2021 and Beyond - The Scientist - February 2nd, 2021
- Bone Therapeutics, Rigenerand Ink Cell Therapy Deal - Contract Pharma - January 19th, 2021
- Bone Therapeutics and Rigenerand sign partnership for cell therapy process development - GlobeNewswire - January 19th, 2021
- Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing - Science Advances - December 10th, 2020
- MPN Driver Mutations Can Be Acquired as Early as in Utero, Study Shows - Targeted Oncology - December 10th, 2020
- Accumulated genetic variations: What they are and why they matter to a complete health picture - MedCity News - December 3rd, 2020
- The South and Central America cell therapy instruments market is expected to reach US$ 462.05 million in 2027 from US$ 1,074.99 million in 2019 -... - November 25th, 2020
- Non-hereditary mutation acts as natural gene therapy for GATA2 deficiency - Health Europa - November 18th, 2020
- Cell Therapy Market Attractiveness, Competitive Landscape and Key Players MEDIPOST, Kolon TissueGene, NuVasive, Fibrocell Science - The Think... - November 18th, 2020
- Minaris invests to triple capacity in Europe - Bioprocess Insider - BioProcess Insider - November 9th, 2020
- Cell Therapy Manufacturing Market: Applications and Regional Insights During the Forecasted Period 2020-2030 - PRnews Leader - November 9th, 2020
- Minaris Regenerative Medicine to Significantly Expand Manufacturing Capacity for Cell and Gene Therapies in Germany and Japan - b3c newswire - November 3rd, 2020
- The Zinc Finger Nuclease Technology market to witness an incremental CAGR between 2020 and 2030 - Eurowire - November 3rd, 2020
- Technological Innovations and Pandemic Analysis Till 2030: Cell Therapy Manufacturing Market - Eurowire - October 28th, 2020
- Novel Strategies for Targeting the Guardian of the Genome Emerge - OncLive - October 23rd, 2020
- SFARI | New collaboration between SFARI and Nancy Lurie Marks Family Foundation will generate hundreds of iPSC lines for autism research - SFARI News - October 21st, 2020
- Five Indian American Researchers Named Among NIH 2020 New Innovator Awardees - India West - October 21st, 2020
- A pathway to nowhere? A critique of the National Academy of Sciences report on genome editing - BioNews - October 13th, 2020
- Large-scale RNAi screening uncovers therapeutic targets in the parasite Schistosoma mansoni - Science Magazine - September 25th, 2020
- Strategic Analysis to Understand the Competitive Outlook of Cell Therapy Manufacturing Market - The News Brok - September 3rd, 2020
- Stem Cells Market Development Status, Emerging Technologies, Regional Trends and Comprehensive Research Study 2025 - The Daily Chronicle - August 28th, 2020
- Cell Therapy Manufacturing Market To Experience Significant Growth During The Forecast Period 2020-2029 - Scientect - August 28th, 2020
- Cell Therapy Manufacturing Market 2020 Report Including COVID-19 Impact Analysis and Forecast till 2029 - Scientect - August 22nd, 2020
- Cell Therapy Market Opportunities, Threats, Trends, Applications, And Growth Forecast To 2027 | MEDIPOST, Osiris Therapeutics, NuVasive, Cells for... - August 22nd, 2020
- Outlook on the Worldwide Hunter Syndrome Industry to 2030 - ResearchAndMarkets.com - Yahoo Finance - August 7th, 2020
- Edited Transcript of CLDX.OQ earnings conference call or presentation 6-Aug-20 8:30pm GMT - Yahoo Finance - August 7th, 2020
- Gene Therapy Market By Industry Type, By Brand And Major Players 2020-2027 - Market Research Posts - August 6th, 2020
- CAREDX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com - August 4th, 2020
- Tooth Regeneration Market Size -Future of growth, Top Capital Facts, Global Industry Analysis, Share, Growth, Trends and Forecast 2020 - 2025 - Market... - July 29th, 2020
- Somatic Stem Cells | SpringerLink - July 29th, 2020
- -Catenin safeguards the ground state of mousepluripotency by strengthening the robustness of the transcriptional apparatus - Science Advances - July 19th, 2020
- COVID-19 Impact on Cell Therapy Industry 2020: Global Market Size, Share, Emerging Trends, Business Growth Applications, SWOT Analysis by Top Key... - July 17th, 2020
- Somatic Cells: Meaning, Characteristics, Types and Examples - July 15th, 2020
- Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners - BusinessGhana - July 10th, 2020
- Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners - Business Wire - July 10th, 2020
- Global Tooth Regeneration Market : Industry Analysis and Forecast (2020-2027)-by Type, Application, Population Demographics and Region. - Morning Tick - July 6th, 2020
- REGENERATIVE MEDICINE MARKET ALONG WITH COVID-19 IMPACT ANALYSIS AND CLINICAL OUTLOOK 2022 | STRYKER CORPORATION, ZIMMER BIOMET HOLDINGS INC.,... - July 2nd, 2020
- Outlook on the Worldwide Regenerative Medicine Industry to 2024 - Rising Global Healthcare Expenditure Presents Opportunities - GlobeNewswire - June 25th, 2020
- Estrogen induces dynamic ER and RING1B recruitment to control gene and enhancer activities in luminal breast cancer - Science Advances - June 8th, 2020
- Participation of Somatic Stem Cells, Labeled by a Unique ... - June 5th, 2020
- COVID-19 Impact on Global Cell Therapy Industry 2020: Market Trends, Size, Share, Applications, SWOT Analysis by Top Key Players and Forecast Report... - June 5th, 2020
- A caveolin binding motif in Na/K-ATPase is required for stem cell differentiation and organogenesis in mammals and C. elegans - Science Advances - June 1st, 2020
- Global Tooth Regeneration Market : Industry Analysis And Forecast (2020-2027) - Azizsalon News - May 14th, 2020
- Somatic Stem Cells - Methods and Protocols | Shree Ram ... - May 13th, 2020
- What is the Value of iPSC Technology in Cardiac... - The Doctor Weighs In - May 7th, 2020
- Induced Pluripotent Stem Cells Market Latest Trends and Analysis Future Growth Study by 2029 Cole Reports - Cole of Duty - May 4th, 2020
- Global Zinc Finger Nuclease Technology Market to Generate Lucrative Revenue Prospects for Manufacturers After the End of COVID-19 Crisis and Forecast... - May 4th, 2020
- Normal human uterus is colonised by clones with cancer-driving mutations that arise early in life, study finds - Cambridge Network - April 24th, 2020
- Global Tooth Regeneration Market: Industry Analysis and Forecast (2020-2027) - Publicist360 - April 17th, 2020
- Scientists 'Reset' The Age of Stem Cells From a Supercentenarian Who Lived to 114 - ScienceAlert - March 25th, 2020
- Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia - BioSpace - March 11th, 2020
- Mapping the structure and biological functions within mesenchymal bodies using microfluidics - Science Advances - March 4th, 2020
- Researchers ID Protein-Protein Interaction That Promotes Cancer Development - BioSpace - February 28th, 2020
- Dental Regenerative Market Size, Share 2020 Regional Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by... - February 28th, 2020
- Global Gene Therapy Market to Cross Around USD 6892 Million By 2027 - Global Newspaper 24 - February 17th, 2020
- Induced Pluripotent Stem Cells Market Predicted to Witness Surge in the Near Future2018 2028 - TechNews.mobi - February 15th, 2020
- Global Gene Therapy Market Worth Reach USD 6892 Million By 2027 - TheInfobiz - February 12th, 2020
- New research shows what happens to your lung cells once you quit smoking - Daily Gaming Worlld - February 9th, 2020
- Global Gene Therapy Market to Cross USD 6892 Million By 2027 - TheInfobiz - February 6th, 2020
- Scientists finally find link between stress and grey hair - nation.co.ke - January 31st, 2020
- Global Gene Therapy Market is Growing to Reach 6892 Million By 2027 - Market Research News 24 - January 29th, 2020
- Going Gray Too Soon? Scientists Say It Really May Be Due to Stress - Genetic Engineering & Biotechnology News - January 25th, 2020
- Allele and Astellas Enter into an Expanded License for the Development of iPSC Lines - Business Wire - January 20th, 2020
- Stem Cells Market- What Are The Main Factors That Contributing Towards Industry Growth? - Industry Mirror - December 31st, 2019
- What a time to be alive: Reproductive breakthroughs of the 2010s that changed life as we know it - FOX 10 News Phoenix - December 29th, 2019
- Gene Therapy Market 2019-2027 / Trends, Growth, Opportunities And Top Key - Market Research Sheets - December 27th, 2019
- Cell Therapy Industry Applications 2019-Size by Type (Allogenic Therapies), by Technique (Stem Cell Therapy), Global Market Growth by Demand Analysis... - December 13th, 2019
- Stem Cell Therapies Market research Likely to Emerge over a Period of 2015-2025 - PharmiWeb.com - December 13th, 2019